# Filana Therapeutics, Inc.: Form 8-K, filed Oct 20, 2026

- Company: [Filana Therapeutics, Inc.](/companies/flna.md) (CIK 1069530)
- Form: 8-K
- Filed: 2026-10-20
- Accepted by EDGAR: Oct 20, 2026, 08:17 ET
- Period: 2026-10-20
- Accession: 0001437749-26-032971
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1069530/000143774926032971/sava20261019_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1069530/000143774926032971/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1069530/000143774926032971/sava20261019_8k.htm

Filed Oct 20, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-032971. Last ingested by Listed: Nov 5, 2026, 16:57 ET. No prices; not investment advice.